Email Updates

You are here

COVID-19 and HIV

There’s much we do and don’t know about COVID-19 and the virus that causes it. The global response to COVID-19, which is evolving rapidly, can and must benefit from lessons learned in the fight against HIV. AVAC is committed to data-driven, evidence-based advocacy, and we hope these resources help us all stay up-to-date on the facts, share experiences and make sure interventions for COVID-19 and HIV reach those who need them the most.

Table of Contents

Action Alerts

These COVID Action Alerts are for HIV advocates whose expertise, interests, skills and voices are needed to influence and expedite an ethical, equitable and effective pandemic response.

COVID News Brief

AVAC’s weekly COVID News Brief provides a curated perspective on what COVID news is worth your time.

Recent Issues

View the archive and sign up!

COVID and HIV Webinar Series

  • Discussion with Jon Cohen on HIV and COVID-19 Vaccine Research (May 13)
    How long until there’s a vaccine against COVID-19? How is COVID vaccine research moving so quickly? How do we ensure COVID research happens ethically? Jon Cohen, one of the leading journalists covering both HIV and COVID, joined us to discuss.
    Recording and slides available here.

Essential Resources

  • How COVID-19 Must Transform US Global Health Strategy
    Writing in The Hill, AVAC Executive Director Mitchell Warren and President of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria Chris Collins challenge us not just to survive this crisis but to seize this moment and begin work on a more sustainable future – one in which the next global pandemics land in a more prepared, more secure and healthier world.
  • Resources for Advocates
    Regularly updated and curated list of sources on a range of issues related to COVID-19, including prevention and transmission, the research pipeline and country-specific resources.
  • COVID-19 Pipeline
    A collaborative project of the COVID-19 Working Group NY, the PrEP4All Collaboration and Treatment Action Group, this COVID-19 Pipeline offers concise overviews and analyses of key research areas.
  • COVID-19 Implications on HIV Prevention Trials
    The world is grappling with the far-reaching impacts of the COVID-19 pandemic and the HIV prevention field is no different. Most trials investigating new biomedical HIV prevention products have paused, citing concerns for the safety of trial participants and the study teams. How COVID-19 is impacting research varies by trial and site, and efforts are ongoing to minimize impact on trial timelines and data. AVAC will continue to monitor developments—watch this space.
  • Research Process Basics
    Tony Fauci, NIAID Director and member of the White House Coronavirus Task Force, provides a 5-minute tutorial on product development and the research process (excerpted from the March 26 White House briefing).
  • COVID-19: Special Considerations for People Living with HIV
    This document on COVID-19 considerations for people living with HIV (PLWH) is intended as a resource for clinicians and public health officials. The information is based on best practices in areas that have been heavily impacted by COVID-19 and will be updated as new information and data become available.
  • Online COVID-19 Treatment Resources
    Developed by the University of Washington, this is on-line resource for quality COVID-19 treatment information. It provides a compendium of clinical resources, including summary data, information on on-going clinical trials, and permission-free teaching slide-decks.

Have a resource to add or one you’d like to see? Please be in touch!